Bronchiolitis Obliterans Syndrome
📧 Sign up to get email alerts when something new happens for Bronchiolitis Obliterans Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) [Phase 3]
The Phase 3 extension trial BOSTON-3 evaluating liposomal cyclosporine A added to standard of care for bronchiolitis obliterans syndrome in …
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib [Phase 2]
This clinical trial update describes a Phase 2 rollover study of Itacitinib to provide continued treatment for participants previously enrol…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant [Phase 1]
This Phase 1 trial evaluated Itacitinib for bronchiolitis obliterans syndrome after donor hematopoietic cell transplant and has been termina…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2 [Phase 3]
This document reports a completed Phase 3 trial evaluating nintedanib in lung transplant recipients with bronchiolitis obliterans syndrome.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Safety and Efficacy of Itacitinib in Participants With Bronchiolitis Obliterans Syndrome Following Lung Transplantation [Phase 1, Phase 2]
Itacitinib was studied for safety and efficacy in Bronchiolitis Obliterans Syndrome after lung transplantation. The Phase 1/2 trial was term…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Early Detection and Management of Bronchiolitis Obliterans Syndrome Following Pediatric Hematopoietic Stem Cell Transplantation
Completed clinical trial evaluating early detection and management of bronchiolitis obliterans syndrome after pediatric hematopoietic stem c…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell Transplantation [NA]
Completed clinical trial evaluating pulmonary MRI as a diagnostic tool for bronchiolitis obliterans syndrome after allogeneic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) [Phase 2]
Phase 2 safety study of liposomal cyclosporine A for bronchiolitis after hematopoietic cell transplantation was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome [Phase 2]
Phase 2 trial update on ruxolitinib for newly diagnosed bronchiolitis obliterans syndrome with hematologic malignancy.
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome [Phase 2]
Phase 2 trial evaluating cyclosporine inhalation solution for bronchiolitis obliterans syndrome in lung transplant and hematopoietic stem ce…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 3]
Phase 3 trial evaluating whether azithromycin prevents bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantation [NA]
A completed clinical trial evaluating whether forced oscillation measurements can aid in diagnosing bronchiolitis obliterans syndrome in pat…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients [NA]
Clinical trial completion evaluating electrical impedance tomography for diagnosing chronic rejection in heart-lung transplant recipients.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Early Indicators of Chronic Rejection in Lung Transplant
This terminated clinical trial assessed early indicators of chronic rejection in lung transplant recipients, examining cytokine production a…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
The trial assessed correlations among lung biopsy, bronchoalveolar lavage, and high-resolution CT findings in lung transplant recipients wit…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Forced Oscillation Versus Spirometry in Diagnosing Post Pulmonary Transplant Bronchiolitis Obliterans Syndrome [NA]
A completed clinical trial compared forced oscillation to spirometry for diagnosing bronchiolitis obliterans syndrome after lung transplanta…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) [Phase 4]
Phase 4 safety trial evaluating aztreonam lysine for inhalation (AZLI) in early bronchiolitis obliterans syndrome; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Vitamin D in Bronchiolitis Obliterans Syndrome [Phase 4]
A Phase 4 clinical trial evaluating the use of Vitamin D for bronchiolitis obliterans syndrome in lung transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients [Phase 2, Phase 3]
A Phase 2/3 study evaluating liposomal cyclosporine A (L-CsA) to prevent bronchiolitis obliterans syndrome in lung transplant recipients has…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Montelukast in Bronchiolitis Obliterans Syndrome [Phase 4]
A Phase 4 clinical trial evaluating montelukast in bronchiolitis obliterans syndrome after lung transplantation has completed. The study als…
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation [Phase 3]
Phase 3 trial of Cyclosporine Inhalation Solution (CIS) in lung transplant recipients completed, evaluating bronchiolitis obliterans syndrom…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Azithromycin in Bronchiolitis Obliterans Syndrome [Phase 4]
Phase 4 trial update evaluating azithromycin in Bronchiolitis Obliterans Syndrome, including graft rejection and related respiratory conditi…
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation [NA]
A clinical trial evaluating extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantation has been terminate…
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients [Phase 2]
A Phase 2 clinical trial evaluating inhaled alpha-1 antitrypsin for preventing bronchiolitis obliterans syndrome in lung transplant recipien…
-
CLINICAL_TRIALS trial_result · 2007-02-07Clinical Trial Update: Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome [EARLY_Phase 1]
This entry describes an early-phase 1 clinical trial evaluating a dry powder inhalation formulation of cyclosporine A in lung transplant rec…